Structure-function relationship and evolutionary history of the human selenoprotein M (SelM) found over-expressed in

Stefano Guariniello1, Giovanni Colonna1, Raffaele Raucci1

  • 1Biochemistry, Biophysics and General Pathology Department and Computational Biology Doctorate, Second University of Naples, Naples, Italy.

Insights

Selenoprotein M (SelM) is investigated for its role in liver cancer. Researchers found SelM expression altered in hepatocellular carcinoma, suggesting its potential as a cancer marker and therapeutic target.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • Humans possess 25 selenoproteins crucial for redox regulation, detoxification, immune function, and viral suppression.
  • Selenoprotein M (SelM), a thiol disulfide oxidoreductase, is involved in disulfide bond formation and calcium responses, with a redox motif (CXXU).
  • SelM's expression, modulated by dietary selenium, impacts redox homeostasis, but its role in cancer remains unexplored, with existing research focused on neurodegenerative diseases.

Purpose of the Study:

  • To investigate the expression of SelM in hepatocellular carcinoma (HCC) cell lines compared to normal hepatocytes.
  • To analyze the structure-function relationships of SelM, including its evolutionary history and structural dynamics.
  • To explore the potential of SelM as a biomarker for HCC progression and as a target for structure-based drug design.

Main Methods:

  • Phylogenetic analysis and gene GC content analysis to study SelM's evolutionary history.
  • Molecular dynamics simulations to model the three-dimensional structure and energetic stability of human SelM.
  • Modeling of SelM mutants to gather structural insights for drug design.

Main Results:

  • SelM expression was evaluated in HepG2 and Huh7 hepatoma cell lines relative to normal hepatocytes.
  • Findings suggest SelM's involvement in hepatocellular carcinoma.
  • The study provides structural and evolutionary insights into SelM, potentially aiding in drug development.

Conclusions:

  • SelM expression is altered in hepatocellular carcinoma, indicating its potential role in liver cancer.
  • SelM may serve as a prognostic marker for HCC progression.
  • Structural and evolutionary analyses of SelM offer a foundation for developing targeted therapies.